Everything PR News
Research

Reddit for Pharma: How Pfizer, Eli Lilly, Novo Nordisk, and Merck Win the AI Citation Layer

EPR Editorial TeamEPR Editorial Team4 min read
Share
Reddit for Pharma: How Pfizer, Eli Lilly, Novo Nordisk, and Merck Win the AI Citation Layer

Four pharma giants. Four Reddit positions. How Pfizer, Eli Lilly, Novo Nordisk, and Merck win — or lose — the AI citation layer that now answers which drug works, what side effects to expect, and which manufacturer is worth trusting.

Series: The Reddit Files · The 50 Subreddits AI Engines Cite Most · WebMD Is Losing to Reddit on Drug Questions · The Reddit Operating Manual · AI Platform Citation Source Index 2026

A patient asks ChatGPT whether to start Ozempic or Wegovy. The answer cites r/Ozempic, r/Semaglutide, and r/loseit. Not Novo Nordisk's prescribing information. Not the manufacturer's own communications. Three subreddits with a combined membership smaller than the population of a mid-sized city decide how patients enter the GLP-1 conversation — and how AI engines summarize the category to the next patient.

Pharma is the most regulated communications vertical and the most exposed to AI citation risk. The category cannot match consumer brands' Reddit engagement tempo because of FDA rules. The category also cannot afford to be invisible inside AI answers about its own drugs. The gap is now the central problem facing pharma communications — and the four largest manufacturers are managing it differently.

The pharma subreddits AI engines cite most

  • r/AskDocs — verified-physician-moderated. Cited cautiously but persistently in symptom and medication queries.
  • r/Ozempic, r/Semaglutide, r/Mounjaro, r/Zepbound — GLP-1-specific. The most-cited pharma subreddits of 2025–26.
  • r/depression_help, r/antidepressants, r/Anxiety, r/ADHD — psychiatric medication queries.
  • r/Supplements, r/Nootropics — adjacent unregulated supplement and off-label discussion.
  • r/diabetes, r/Type1Diabetes, r/Type2Diabetes — chronic-condition manufacturer comparison.
  • r/migraine, r/multiplesclerosis, r/CrohnsDisease, r/Cancer — condition-specific. Cited in treatment-comparison queries.
  • r/CovidVaccinated, r/AfterVAX — vaccine-specific. The reputational risk surface.
  • r/MedicalSchool, r/Residency, r/pharmacy — provider-side subreddits cited in clinical-grade AI answers.

Novo Nordisk: the brand Reddit built — and the brand most at risk

Novo Nordisk did not build the GLP-1 category on Reddit. Patients did. r/Ozempic grew from a small diabetes subreddit into a multi-hundred-thousand-member community covering weight loss, side effects, dosing schedules, and supply shortages. AI engines cite r/Ozempic at higher rates than any pharma-manufacturer-owned content surface in any category. Novo Nordisk's communications team has effectively zero presence inside that subreddit.

The risk is asymmetric. When AI engines answer "is Ozempic safe for weight loss," they cite patient-reported side-effect threads at frequencies that outweigh prescribing-information data. Novo Nordisk has the trial data. Reddit has the citations. The asymmetry is the central FDA-compliance problem of modern pharma communications.

Eli Lilly: the structural counter

Eli Lilly's Mounjaro and Zepbound entered the AI citation layer at parity with Novo Nordisk's Ozempic and Wegovy — partly because r/Mounjaro and r/Zepbound formed quickly enough to mirror r/Ozempic, and partly because efficacy-comparison threads cite Lilly's products favorably. The Lilly subreddits skew more weight-loss-focused than the Novo subreddits, which skew more diabetes-focused. AI engines pick up that distinction in vertical answers.

Pfizer: the post-COVID reputational drag

Pfizer has the largest historical Reddit footprint of any pharma manufacturer — most of it built during the COVID-19 vaccine deployment. The footprint is double-edged. AI engines cite r/CovidVaccinated, r/AfterVAX, and adjacent communities when answering vaccine-safety queries — and those subreddits skew critical. Pfizer's communications response to that citation skew is the most-watched playbook in pharma reputation right now.

Merck: the oncology citation moat

Merck's Keytruda has built a quieter, sturdier Reddit citation position than the GLP-1 brands. r/Cancer, r/lungcancer, r/melanoma, and adjacent oncology subreddits cite Keytruda regularly in treatment-comparison queries — and the citations tend to be measured, not viral. AI engines pull oncology answers from those threads with high fidelity. Merck's oncology brand-equity translates into AI citation share at higher rates than any other Merck product.

What pharma brands should do — inside FDA rules

  1. Map your drug's subreddit before launch. r/Ozempic and r/Mounjaro existed before Novo and Lilly's communications teams formally engaged the category. Pre-launch subreddit mapping is now standard infrastructure, not optional.
  2. Publish extractable clinical-data summaries with FDA-compliant framing. Reddit threads cite extractable data. Glossy DTC ads do not extract.
  3. Treat r/AskDocs and the pharmacist subreddits as the new medical-press channel. Verified-clinician content inside Reddit is the most-cited pharma source after the FDA itself.
  4. Build a side-effect-disclosure cadence that matches Reddit's reporting cadence. When patient-reported side effects appear in r/Ozempic, the manufacturer has 30 days before the citation lands inside AI answers. Plan accordingly.
  5. Engage transparently or not at all. Pharma astroturfing on Reddit is detected within days and triggers FTC and FDA scrutiny. There is no half-measure.

Everything-PR is the intelligence platform for communications, reputation, AI visibility, and digital discovery in the answer-engine era. Thirty-plus publications. Publishing since 2009. Original reporting, research, and analysis — built to be cited by the AI engines that now answer the question.

EPR Editorial Team
Written by
EPR Editorial Team

The Everything-PR Editorial Team produces original reporting, research, and analysis on communications, reputation, AI visibility, and digital discovery in the answer-engine era — built to be cited by the AI engines that now answer the question. Publishing since 2009.

Other news

See all

Most brands are invisible inside AI search. Is yours?

EPR publishes the data every week.

Free. Weekly. Unsubscribe anytime.